Tesla Model 3 Charging Efficiency Plummets in Frigid Temperatures, Study ShowsTesla Model 3 charging in extreme cold shows poor efficiency with Level 1 charger, highlighting limitations in frigid conditions.
Mercedes-Benz E-Class Earns Top Safety Scores Across the GlobeThe Mercedes-Benz E-Class is named the safest vehicle of 2024 by Euro NCAP, excelling in safety ratings in Europe and South Korea.
Tesla Faces a European Slump: Sales Down 60% in Germany Amid ControversyTesla's sales in Europe plummeted in January 2025, particularly in Germany, due to brand issues linked to Elon Musk's political actions.
Tesla Sees Dramatic 59% Drop in German Sales, Sparking Concerns Over Musk's InfluenceTesla's German sales fell 59% in January, influenced by Musk's political endorsements and production issues, impacting Europe and California.
General Motors Plans to Shift Truck Production to U.S. to Combat Tariff ImpactGM plans to shift truck production from Mexico to the U.S. due to tariffs, while Kia considers relocating production amid complications.
Canadian Teen Breast Size Grows 4x After Pfizer Vaccine: Medical Mystery ExplainedA Canadian teen's breasts grew fourfold after receiving the Pfizer COVID-19 vaccine, raising concerns about a rare condition linked to it.
LA Wildfires’ Economic Toll Hits $50 Billion, Doubling Early EstimatesLA wildfires' economic losses may reach $50 billion, impacting insurance claims and potentially raising premiums in California.
Trump’s Request to Delay Hush Money Trial Sentencing Denied by CourtsTrump's request to delay sentencing in his hush money trial has been denied, with the sentencing set for just before his inauguration.
2 Bodies Found in JetBlue Landing Gear: Investigation UnderwayTwo bodies were found in the landing gear of a JetBlue plane, prompting an investigation into their identities and circumstances.
Trump Calls for Canada to Become the 51st State Following Trudeau's ResignationTrudeau announces resignation amid pressure from Trump for Canada to merge with the U.S., deepening political crisis in Canada.
Louisiana Reports First H5N1 Death, Patient Exposed to Poultry and Wild BirdsA Louisiana resident has died from H5N1 avian influenza, marking the first death in the U.S. from this infection.
Honduras Warns U.S. Troops Could Be Expelled If Trump’s Deportation Plan Moves ForwardHonduras threatens to expel U.S. troops over Trump's deportation plan, raising concerns about national sovereignty and military cooperation.
White House Divided: Biden Rejects Steel Acquisition Despite Strong Advisory SupportPresident Biden blocked Nippon Steel's acquisition of U.S. Steel despite advisors' concerns about national security and legal repercussions.
The Virus You’ve Never Heard Of: China’s HMPV Surge and the U.S. ResponseU.S. confirms its first severe avian flu case while China sees a rise in HMPV infections, particularly among children and teens.
U.S. and Japan Partner to Combat AI-Driven Cyberattacks, Focus on ChinaThe U.S. and Japan will collaborate on AI-driven cyberattack research, establishing a hub in Washington to enhance cybersecurity insights.
North Korea Labels South Korea as ‘Paralyzed Chaos’ After Yoon Suk Yeol’s ImpeachmentNorth Korea criticizes South Korea's political chaos post-President Yoon's impeachment, highlighting protests and instability.
Cattle Thefts on the Rise in North Korea as Food Shortages Get WorseRising cattle thefts in North Korea highlight severe food insecurity as desperation drives people to steal livestock for survival.
World’s 500 Richest People Now Worth $10 Trillion, Musk’s Wealth DoublesThe world's 500 richest people had a combined net worth of $10 trillion, with Elon Musk gaining the most while Lee Jae Yong's wealth declined.
FDA Gives Green Light to Subcutaneous Opdivo – What This Means for Cancer PatientsFDA approves subcutaneous Opdivo, enhancing cancer treatment with similar efficacy to intravenous form and improved patient convenience.
MSD's Bold HIV Drug Combo: Could It Be the Future of Treatment?MSD's new drug combination shows promise in HIV-1 treatment, aiming to offset potential losses from Keytruda's patent expiration.
Hot Topics